Viewing StudyNCT02278120

Home Icon Home Search Icon Search Alerts Icon Stocks Certify Doc Icon Certify Doc Certify Doc Icon Genes Certify Doc Icon Clinical Trials Certify Doc Icon CompTox Processes Icon DrugMatrix Open Targets Icon Open Targets Processes Icon Products Support Icon Support Bugs Icon Bugs eRecord Icon eRecord
Main Search All Studies All Organizations Report Bug
View Study With Definitions
Ignite Creation Date: 2024-05-06 @ 3:22 AM
Last Modification Date: 2024-10-26 @ 11:33 AM
Study NCT ID: NCT02278120
Status: COMPLETED
Last Update Posted: 2024-03-12
First Post: 2014-10-22
Brief Title: Study of Efficacy and Safety in Premenopausal Women With Hormone Receptor Positive HER2-negative Advanced Breast Cancer
Sponsor: Novartis Pharmaceuticals
Organization: Novartis
Overview Dates Organization Conditions Design Enrollment Locations Outcomes

Conditions & Keywords Data

Conditions:
Name
Advanced Metastatic Breast Cancer
Keywords:
Name View
Premenopausal View
LEE011 View
ribociclib View
HR-positive View
HER2-negative View
Advanced breast cancer View
Letrozole View
Anastrozole View
Tamoxifen View
Goserelin View
CDK View
CDK4 View
CDK6 View
CDK46 View
Phase III View
ER-positive View
PR-positive View